Famous doctor's free clinic | Wang Junjie, chairman of the Radiation Oncology Branch of the Chinese Medical Association and an expert team from Peking University Third Hospital will go to the Second People's Hospital of Baiyin City for free clinics, ward rounds, and academic exchanges.

The "Mother's River · Cancer Prevention and Treatment Public Welfare Project - Experts Grassroots Tour," organized by the Bethune Charitable Foundation, is scheduled to take place at Baiyin City Second People's Hospital on Friday, May 30, 2025.

This event is led by Professor Wang Junjie, Chairman of the Radiotherapy Oncology Branch of the Chinese Medical Association and Director of the Department of Radiation Oncology at Peking University Third Hospital. It brings together leading experts in cancer treatment to Baiyin City Second People's Hospital for a series of activities, including **free medical consultations, ward rounds, and academic exchanges**, aiming to fully meet the healthcare needs of cancer patients in the region.

Event Schedule

Free Medical Consultation

Time: May 30 (Friday), 9:30 AM – 11:30 AM

Location: Second-floor lobby, Outpatient Department, Baiyin City Second People’s Hospital

Target Patients: Individuals with malignant tumors, including breast cancer, lung cancer, esophageal cancer, liver cancer, colorectal cancer, cervical cancer, etc.

Registration: Please make an appointment via phone three days in advance

Reminder: Patients are advised to bring relevant medical records from the past three months (including but not limited to pathology reports, imaging data, lab test results, treatment history, and previous diagnosis summaries) to facilitate a comprehensive evaluation and precise medical advice from the experts.

Contact Information:

Dr. Ma Jianwei (Director, General Surgery I): 189-9395-8899

Dr. Wang Caiming (Director, General Surgery III): 138-9306-9902

Dr. Zhang Anxing (Director, Gastroenterology): 138-8426-8731

Dr. Zhang Xianjun (Director, Respiratory Medicine): 136-1930-8355

Dr. Luo Rurong (Director, Gynecology): 138-9302-6629

Dr. Bai Gengshen (Director, Interventional Medicine): 139-1993-2441

Academic Exchange Session

Time: May 30 (Friday), 8:20 AM – 11:30 AM

Location: 15th-floor Conference Room, Pediatric Specialty Ward, Baiyin City Second People’s Hospital

Project Overview

Mother’s River · Cancer Prevention and Treatment Public Welfare Project

The Mother’s River · Cancer Prevention and Treatment Public Welfare Project is spearheaded by Professor Wang Junjie, Chairman of the Radiotherapy Expert Committee of the Bethune Charitable Foundation. The project’s name draws inspiration from the song "Father’s Grassland, Mother’s River," symbolizing the profound love for one’s homeland and the enduring bond with family.

Aligned with the Healthy China strategy and the national call for high-quality medical services, this initiative brings together multidisciplinary expert teams from leading tertiary hospitals. Leveraging their integrated medical, educational, and research resources, the project provides comprehensive support to grassroots healthcare institutions, including:

• Technical guidance & specialized training
• Expert consultations & continuing education
• Research collaboration & academic exchanges
• Radiation oncology specialty development

By enhancing the capabilities of county-level hospitals in cancer radiotherapy, the project also facilitates:

• Public health education on cancer prevention
• Free screening clinics & targeted medical assistance
• Charitable aid programs for underserved patients

These efforts aim to reduce cancer incidence and mortality, improve survival rates, and alleviate poverty caused by illness, ensuring equitable access to advanced cancer care across regions.

Expert Delegation

Wang Junjie, M.D.

Chief Physician, Professor, Doctoral Supervisor

Current Positions:

• Director, Department of Radiation Oncology, Peking University Third Hospital
• Director, Brachytherapy Center, Peking University Health Science Center
• Founding Chair, Department of Radiation Oncology, Peking University Health Science Center
• President, Lanzhou Heavy Ion Hospital

Clinical Expertise:

Specializing in comprehensive cancer treatment, including:

• Radiotherapy, Chemotherapy, Targeted Therapy & Immunotherapy
• Minimally Invasive Techniques:Lung nodule biopsyCyberKnife®-based Stereotactic Body Radiotherapy (SBRT)Radioactive seed implantation (brachytherapy)
• Multidisciplinary Management of:Head & neck cancersLung/liver/pancreatic/prostate cancersSoft tissue sarcomas

Leadership in Academic Societies:

• Chairman, 10th Committee of Radiotherapy Oncology Branch, Chinese Medical Association
• President, 1st & 2nd Council of Brachytherapy & Smart Radiotherapy Society, Chinese Nuclear Society

Editorial Roles:

• Editor-in-Chief, Advances in Radiotherapy & Nuclear Medicine
• Editorial Board Member, Brachytherapy (U.S. journal)
• Associate Editor, Chinese Journal of Radiological Medicine and Protection
• Associate Editor, Chinese Journal of Radiation Oncology

Jiang Yuliang, M.D.

Associate Chief Physician
Department of Radiation Oncology, Peking University Third Hospital

Leader, Particle & Minimally Invasive Therapy Group

Clinical Expertise:

• Radiotherapy for systemic malignancies, with focus on:Head & neck cancersCyberKnife® SBRT (for lung/liver/pancreatic tumors, bone/brain metastases)Radioactive seed implantation (brachytherapy)CT-guided biopsies in complex anatomical sites

Professional Affiliations:

• Beijing Medical Association Radiotherapy Society:Member, Head & Neck Oncology Working GroupMember, Central Nervous System Working GroupMember, Stereotactic Radiotherapy Working Group
• Standing Committee Member:Radiotherapy Division, Beijing Precision Radiation Medicine SocietyInterstitial Implant Committee, Chinese Anti-Cancer AssociationTumor Radioactive Particle Ablation Committee, National Tumor Minimally Invasive Technology Innovation Alliance
• Deputy Secretary-General:Brachytherapy & Smart Radiotherapy Society, Chinese Nuclear Society
• Committee Member:Digital & Intelligent Surgery Committee, Chinese Research Hospital AssociationRadiotherapy-Immunotherapy Working Group (Beijing), Chinese Radiation Oncology Collaborative Group

Academic Achievements:

• Visiting Scholar, Duke University (U.S.)
• Contributor to 3 provincial/ministerial-level awards
• Co-inventor of 8 patents, co-author of 7 medical textbooks
• First-author publications: 5 SCI-indexed papers, 10 core journal articles

Jiang Weijuan, M.D., Ph.D.

Attending Physician
Department of Radiation Oncology, Peking University Third Hospital

Clinical Expertise:

Specializing in radiotherapy for:

• Thoracic malignancies
• Gynecologic cancers

Professional Affiliations:

• Committee Member, Radiotherapy Specialty Committee, Beijing Breast Disease Prevention & Treatment Society
• Committee Member, Lung Cancer Diagnosis & Treatment Expert Committee, Beijing Health Promotion Association

Wang Huiqin, M.D.

Associate Chief Physician
Lanzhou Maternal and Child Health Hospital

Clinical Expertise:

Specializing in:

• Gynecologic Laparoscopic & Hysteroscopic Surgery
• Transvaginal Minimally Invasive Techniques
• Surgical Treatment of Gynecologic Malignancies

Professional Affiliations:

• Committee Member, Maternal & Child Minimally Invasive Specialty Committee, Gansu Maternal and Child Health Association
• Youth Committee Member, Gynecologic Oncology Society, Gansu Medical Association
• Council Member, Gansu Anti-Cancer Association

Academic & Clinical Achievements:

• Principal Investigator of 5 provincial/municipal research projects2x Municipal Science & Technology Bureau Second PrizeGansu Medical Science & Technology Third PrizeGansu Huangfu Mi Traditional Chinese Medicine Science & Technology Third Prize
• Published 8 peer-reviewed papers (last 5 years)
• Co-author of 1 medical textbook

Awards & Honors:

• 2012: Second Prize, Gansu Provincial Surgical Video Competition
• 2022: First Prize, Lanzhou Gynecologic Endoscopy Skills Competition
• 2023: First Prize, Gansu Provincial Gynecologic Endoscopy Skills Competition
• 2024: First Prize, Lanzhou Endoscopic Skills Competition

Qi Ying

Chief Radiotherapy Technologist

Deputy Director, Lanzhou Branch of Gansu Wuwei Cancer Hospital

Professional Expertise:

• Quality Management Systems for Carbon Ion Therapy
• Radiation Therapy for Malignancies
• Heavy Ion Radiotherapy & Comprehensive Treatment:Head & Neck CancersLung/Esophageal/Breast CancersGynecologic TumorsRehabilitation Therapy

Professional Affiliations:

• Committee Member, Gynecologic Oncology Committee, Western Radiotherapy Association
• Committee Member, Gansu Radiotherapy Specialty Committee
• Council Member, Gansu Anti-Cancer Association
• Vice Chairperson, Gansu Medical Doctor Association
• Chairperson, Radiotherapy Committee, Wuwei Medical Association

Academic Achievements:

• 30+ Peer-Reviewed Publications
• Principal Investigator of 5 Research Projects1st Prize, Wuwei Science & Technology Progress Award
• 16 SCI Papers in National/Provincial Core Journals
  

Zhao Fengju, M.D.

Chief Physician, Professor, Master's Supervisor
Director of Radiotherapy Ward II, Lanzhou Heavy Ion Hospital
Former Chief Physician, Department of Radiotherapy, Gansu Provincial Cancer Hospital

Clinical Expertise:

Specializes in comprehensive treatment of:

• Gynecologic malignancies (cervical/endometrial/ovarian/vulvar/vaginal cancers)
• Breast cancer
• Gastrointestinal tumors
• Abdominopelvic and urologic soft tissue tumors

Treatment modalities:

• Chemoradiotherapy and immunotargeted therapy
• Advanced external beam techniques (IGRT for gynecologic tumors)
• 3D brachytherapy (including 3D printing applications)
• Interstitial implantation for malignant tumors

Professional Leadership:

• Founding Chair, Brachytherapy Committee, Gansu Anti-Cancer Association
• Vice Chair, Western Gynecologic Oncology & Brachytherapy Committee
• Lead, Northwest Gynecologic Oncology Collaborative Group & Brachytherapy Center
• Committee Member:Gynecologic Oncology Committee, Chinese Medical Doctor AssociationBrachytherapy Group, Chinese Medical AssociationBrachytherapy Committee, Chinese Anti-Cancer Association
• Invited Expert, Training Department, China Ethnic Health Association
• Editorial Board Member, Diseases & Research

Academic Achievements:

• 20+ publications (including 3 SCI papers)
• Awarded:2 Second Prizes, "Huangfu Mi" Award2 Third Prizes, "Huangfu Mi" Award
• Chief Editor:Treatment Strategies for Gynecologic TumorsComprehensive and Targeted Immunotherapy for Gynecologic Tumors

Chen Yu, M.D.

Associate Chief Physician
Director of Minimally Invasive Interventional Radiotherapy Department
Lanzhou Heavy Ion Hospital

Clinical Expertise:

Specializes in minimally invasive interventional diagnosis and treatment of tumors, combined with:

• Radiotherapy
• Chemotherapy
• Immunotherapy
• Targeted therapy

Pioneering Techniques Performed:

• CT-guided tissue biopsy
• Radioactive seed interstitial implantation
• Transarterial chemoembolization (TACE)
• Hepatic arterial infusion chemotherapy (HAIC)
• CT-guided intratumoral injection therapy
• Tumor ablation techniques

Professional Affiliations:

• Academic Committee Member, China Northern Radioactive Seed Brachytherapy Group (CNRBG)
• Lecturer, Standardized Glucocorticoid Application Tour Lecture Team, Chinese Medical Doctor Association
• Committee Member, Hyperthermia Committee, Hubei Anti-Cancer Association

Academic Achievements:

• Principal Investigator of 4 research projects and 1 teaching project
• Participant in 5 national-level research projects
• 21 publications (including 2 SCI papers)
• Chief Editor of 2 medical textbooks
• Holder of 3 patents
• 6 award-winning papers at provincial/national conferences
• 3 teaching awards from Hubei University of Medicine

Lanzhou Heavy Ion Center

The Lanzhou Heavy Ion Center has established an elite talent system, bringing together a distinguished team of experts. The center features 50 expert workstations led by top authorities in the field, including:Prof. Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiation Oncology, Peking University Health Science Center，Prof. Xu Bo, Standing Committee Member of the Radiotherapy Branch of the Chinese Medical Association.

Under the leadership of Prof. Wang Junjie, Chairman of the Radiotherapy Branch of the Chinese Medical Association and President of the center, the facility provides robust technical support for heavy ion therapy.

The center is equipped with cutting-edge medical devices, including:Varian VitalBeam medical linear accelerator，Elekta Infinity 4D image-guided linear accelerator,  3.0T simulation and positioning MRI, GE 256-slice high-end CT.

These advanced facilities form a solid foundation for heavy ion therapy, ensuring high efficiency and precision in treatment.In collaboration with the first Chinese heavy ion therapy system, the second Chinese heavy ion cancer treatment system commenced clinical operation at the Lanzhou Heavy Ion Center on November 15, 2024.To date, the center has completed 182 cases of photon and heavy ion therapy, covering over 40 disease types, including: Lung cancer, Liver cancer, Glioblastoma.

The facility houses 4 treatment cabins:

1. No. 1 Horizontal Spot-Scanning Terminal
2. No. 2 Horizontal + Vertical Uniform-Scanning Terminal
3. No. 3 Vertical Spot-Scanning Terminal
4. No. 4 45° Uniform-Scanning Terminal